Mind Medicine (mindmed) INC Form 4 insider transactions
Form 4: Mind Medicine (MindMed) Inc. Chief Accounting Officer Receives 50,000 Restricted Stock Units
Carrie Liao, Chief Accounting Officer of Mind Medicine (MindMed) Inc., was granted 50,000 restricted stock units (RSUs) on March 12, 2025, which vest quarterly starting June 1, 2025.
MindMed's CEO, Robert Barrow, sold 19,106 common shares to cover tax obligations related to vested restricted stock units.
Carrie Liao, Chief Accounting Officer of Mind Medicine (MindMed) Inc., sold 2,273 common shares to cover tax obligations related to vested restricted stock units.
MindMed's Chief Medical Officer, Dan Karlin, sold 6,643 common shares on December 26, 2024, to cover withholding tax obligations related to vested restricted stock units.
Mark Sullivan, Chief Legal Officer of Mind Medicine (MindMed) Inc., sold 4,519 common shares on December 26, 2024, to satisfy withholding tax obligations related to vested restricted stock units.
Mind Medicine (MindMed) Inc. director David Gryska purchased 2,500 common shares at $7.17 per share on December 5, 2024.
Carrie Liao, Chief Accounting Officer of Mind Medicine (MindMed) Inc., sold 2,352 common shares on September 25, 2024, to cover withholding tax obligations related to vested restricted stock units.
MindMed's CEO, Robert Barrow, sold 19,771 common shares to cover withholding tax obligations related to vested restricted stock units.
Dan Karlin, Chief Medical Officer of Mind Medicine (MindMed) Inc., sold shares to cover withholding tax obligations related to vested restricted stock units.
Mark Sullivan, Chief Legal Officer of Mind Medicine (MindMed) Inc., sold 4,430 common shares on September 25, 2024, to satisfy withholding tax obligations related to vested restricted stock units.
Director David W. Gryska increased his holdings in Mind Medicine (MindMed) Inc. by purchasing 3,500 common shares on August 23, 2024.
Miri Halperin Wernli, Executive President of Mind Medicine (MindMed) Inc., exercised stock options and sold shares to cover the exercise price and tax obligations.
MindMed's CEO, Robert Barrow, has recently increased his holdings in the company through open market purchases.
Dan Karlin, Chief Medical Officer of Mind Medicine (MindMed) Inc., sold 6,925 common shares on June 25, 2024, to satisfy withholding tax obligations related to vested restricted stock units.
MindMed CEO Robert Barrow sold 15,659 common shares on June 25, 2024, to satisfy withholding tax obligations related to vested restricted stock units.
Mark Sullivan, Chief Legal Officer of Mind Medicine (MindMed) Inc., sold 17,854 common shares to cover withholding tax obligations related to vested restricted stock units.
Director Carol A. Vallone reports the grant of stock options in Mind Medicine (MindMed) Inc.
Director David W. Gryska acquired stock options for 16,506 common shares of Mind Medicine (MindMed) Inc. on June 10, 2024.
Director Roger Crystal reports the acquisition of stock options for Mind Medicine (MindMed) Inc.
Suzanne Louise Bruhn, a director of Mind Medicine (MindMed) Inc., acquired stock options exercisable for 16,506 common shares on June 10, 2024.
Director Andreas Krebs acquired stock options for 16,506 common shares in Mind Medicine (MindMed) Inc. on June 10, 2024.
MindMed's Chief Financial Officer, Schond L. Greenway, reports the withholding of 5,560 common shares to cover tax obligations related to vested restricted stock units.
Dan Karlin, Chief Medical Officer of Mind Medicine (MindMed) Inc., sold 6,578 common shares on March 25, 2024, to satisfy withholding tax obligations related to vested restricted stock units.
MindMed's CEO, Robert Barrow, sold 16,519 common shares on March 25, 2024, to cover withholding tax obligations related to vested restricted stock units.
Miri Halperin Wernli, Executive President of Mind Medicine (MindMed) Inc., reports the acquisition of stock options.
Mind Medicine (MindMed) Inc. reports that CFO Schond L. Greenway was granted stock options for 150,000 common shares on February 27, 2024.
Mark Sullivan, Chief Legal Officer of Mind Medicine (MindMed) Inc., reports the acquisition of stock options.
Dan Karlin, Chief Medical Officer of Mind Medicine (MindMed) Inc., was granted stock options for 150,000 common shares on February 27, 2024.
Carrie Liao, Chief Accounting Officer of Mind Medicine (MindMed) Inc., was granted stock options to purchase 100,000 common shares.
Mind Medicine (MindMed) Inc. CEO Robert Barrow was granted stock options to purchase 400,000 common shares on February 27, 2024.